{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T06:10:54Z","timestamp":1778134254808,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1124\/jpet.117.241406","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T00:20:21Z","timestamp":1497918021000},"page":"450-458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Differential Interaction of Dantrolene, Glafenine, Nalidixic Acid, and Prazosin with Human Organic Anion Transporters 1 and 3"],"prefix":"10.1016","volume":"362","author":[{"given":"Birgitta C.","family":"Burckhardt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Henjakovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohannes","family":"Hagos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Burckhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.117.241406_bib1","doi-asserted-by":"crossref","first-page":"E1339","DOI":"10.3390\/ijms17081339","article-title":"The role of \u03b11-adrenoceptor antagonists in the treatment of prostate and other cancers","volume":"17","author":"Batty","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1124\/jpet.117.241406_bib2","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1124\/jpet.113.203257","article-title":"Substrate-dependent ligand inhibition of the human organic cation transporter OCT2","volume":"346","author":"Belzer","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.117.241406_bib3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1124\/jpet.117.241406_bib4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.pharmthera.2012.07.010","article-title":"Drug transport by organic anion transporters (OATs)","volume":"136","author":"Burckhardt","year":"2012","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.117.241406_bib5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.bcp.2014.11.006","article-title":"Identification of new MRP4 inhibitors from a library of FDA approved drugs using a high-throughput bioluminescence screen","volume":"93","author":"Cheung","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.117.241406_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0005-2736(02)00599-0","article-title":"Renal organic anion transport: a comparative and cellular perspective","volume":"1566","author":"Dantzler","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.117.241406_bib7","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3389\/fphys.2016.00320","article-title":"How do antihypertensive drugs work? Insights from studies of the renal regulation of arterial blood pressure","volume":"7","author":"Digne-Malcolm","year":"2016","journal-title":"Front Physiol"},{"key":"10.1124\/jpet.117.241406_bib8","doi-asserted-by":"crossref","first-page":"31561","DOI":"10.1074\/jbc.M112.388793","article-title":"A substrate binding hinge domain is critical for transport-related structural changes of organic cation transporter 1","volume":"287","author":"Egenberger","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.117.241406_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1751-7915.2008.00063.x","article-title":"Mechanism of action of and resistance to quinolones","volume":"2","author":"F\u00e0brega","year":"2009","journal-title":"Microb Biotechnol"},{"key":"10.1124\/jpet.117.241406_bib10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/BF01980043","article-title":"Comparative bioavailability study of two brands of prazosin-containing tablets in healthy volunteers","volume":"12","author":"Guelen","year":"1990","journal-title":"Pharm Weekbl Sci"},{"key":"10.1124\/jpet.117.241406_bib11","doi-asserted-by":"crossref","first-page":"F56","DOI":"10.1152\/ajprenal.00486.2012","article-title":"Multiple mechanisms of ligand interaction with the human organic cation transporter, OCT2","volume":"304","author":"Harper","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/jpet.117.241406_bib12","doi-asserted-by":"crossref","first-page":"F843","DOI":"10.1152\/ajprenal.00140.2015","article-title":"Human organic anion transporter 2 is distinct from organic anion transporters 1 and 3 with respect to transport function","volume":"309","author":"Henjakovic","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/jpet.117.241406_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00210-003-0764-x","article-title":"Pharmacological characterization of unique prazosin-binding sites in human kidney","volume":"368","author":"Hiraoka","year":"2003","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/jpet.117.241406_bib14","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1124\/dmd.115.065748","article-title":"Organic anion transporter 1 is inhibited by multiple mechanisms and shows a transport mode independent of exchange","volume":"43","author":"Hotchkiss","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.117.241406_bib15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1124\/mol.114.091777","article-title":"A plasma concentration of \u03b1-ketoglutarate influences the kinetic interaction of ligands with organic anion transporter 1","volume":"86","author":"Ingraham","year":"2014","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.117.241406_bib16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/00003088-198005040-00004","article-title":"Clinical pharmacokinetics of prazosin","volume":"5","author":"Jaillon","year":"1980","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.117.241406_bib17","doi-asserted-by":"crossref","first-page":"F1026","DOI":"10.1152\/ajprenal.00169.2011","article-title":"Differential interaction of dicarboxylates with human sodium-dicarboxylate cotransporter 3 and organic anion transporters 1 and 3","volume":"301","author":"Kaufhold","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/jpet.117.241406_bib18","series-title":"Drug Transporters Handb Exp Pharmacol","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-3-642-14541-4_8","article-title":"Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy","author":"Keppler","year":"2011"},{"key":"10.1124\/jpet.117.241406_bib19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2044.2004.03658.x","article-title":"Dantrolene\u2014a review of its pharmacology, therapeutic use and new developments","volume":"59","author":"Krause","year":"2004","journal-title":"Anaesthesia"},{"key":"10.1124\/jpet.117.241406_bib20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pharmthera.2010.02.007","article-title":"Therapeutic implications of renal anionic drug transporters","volume":"126","author":"Masereeuw","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.117.241406_bib21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-pharmtox-011112-140317","article-title":"Renal transporters in drug development","volume":"53","author":"Morrissey","year":"2013","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.117.241406_bib22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1152\/physrev.00025.2013","article-title":"The organic anion transporter (OAT) family: a systems biology perspective","volume":"95","author":"Nigam","year":"2015","journal-title":"Physiol Rev"},{"key":"10.1124\/jpet.117.241406_bib23","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/cphy.c100084","article-title":"Renal transport of organic anions and cations","volume":"1","author":"Pelis","year":"2011","journal-title":"Compr Physiol"},{"key":"10.1124\/jpet.117.241406_bib24","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1124\/mol.63.5.1094","article-title":"Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5","volume":"63","author":"Reid","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.117.241406_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13023-015-0310-1","article-title":"Malignant hyperthermia: a review","volume":"10","author":"Rosenberg","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1124\/jpet.117.241406_bib26","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1124\/dmd.110.036640","article-title":"Interactions of green tea catechins with organic anion-transporting polypeptides","volume":"39","author":"Roth","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.117.241406_bib27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tips.2008.01.006","article-title":"Multidrug resistance protein 4 (MRP4\/ABCC4): a versatile efflux transporter for drugs and signalling molecules","volume":"29","author":"Russel","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.117.241406_bib28","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1097\/01.ASN.0000143473.64430.AC","article-title":"Contribution of multidrug resistance protein 2 (MRP2\/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter","volume":"15","author":"Smeets","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/jpet.117.241406_bib29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1124\/jpet.105.088104","article-title":"A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters","volume":"315","author":"Tahara","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.117.241406_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bdd.693","article-title":"Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology","volume":"31","author":"VanWert","year":"2010","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/jpet.117.241406_bib31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1472-8206.1992.tb00112.x","article-title":"Pharmacokinetics of glafenine and glafenic acid in patients with cirrhosis, compared to healthy volunteers","volume":"6","author":"Vermerie","year":"1992","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1124\/jpet.117.241406_bib32","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1124\/jpet.115.225656","article-title":"The pharmacological and physiological role of multidrug-resistance protein 4","volume":"354","author":"Wen","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.117.241406_bib33","doi-asserted-by":"crossref","unstructured":"Withdrawal of glafenine (1992) Lancet 339:357.","DOI":"10.1016\/0140-6736(92)91670-4"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524196322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524196322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.117.241406","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T15:57:24Z","timestamp":1739980644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524196322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0022356524196322"],"URL":"https:\/\/doi.org\/10.1124\/jpet.117.241406","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential Interaction of Dantrolene, Glafenine, Nalidixic Acid, and Prazosin with Human Organic Anion Transporters 1 and 3","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.117.241406","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}